Selectivity Enabling NanoShells (SENS): A Compendium of Innovative Lipid-Polymer Hybrid Nanoparticles Optimized for Robust Tissue-Selective Delivery of Diverse Payloads with Enhanced Stability, Tolerability and Low Immunogenicity

Session details:

• Highlighting Samyang Biopharm’s strengths in biopolymer chemistry & manufacturing and its path from biodegradable surgical sutures and cytotoxic drug formulations to the development of highly differentiated SENS formulations with applications for gene therapy, vaccines, and nucleic acid-encoded biologics.
• Intro to  Samyang’ open innovation model utilizing its versatile  11+ tissue-selective drug delivery platforms thorough strategic partnerships.